Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment

Cardiovascular toxicity is one of the most common complications of chemotherapeutic treatment. The most common method for diagnosing cardiovascular toxicity is to assess the structure and function of the left ventricle.The aim of the study was to investigate structural and functional changes in the...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Chibashova, I. L. Davydkin
Format: Article
Language:Russian
Published: Private institution educational organization of higher education "Medical University "ReaViz" 2025-06-01
Series:Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:
Online Access:https://vestnik.reaviz.ru/jour/article/view/1285
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402678516383744
author A. V. Chibashova
I. L. Davydkin
author_facet A. V. Chibashova
I. L. Davydkin
author_sort A. V. Chibashova
collection DOAJ
description Cardiovascular toxicity is one of the most common complications of chemotherapeutic treatment. The most common method for diagnosing cardiovascular toxicity is to assess the structure and function of the left ventricle.The aim of the study was to investigate structural and functional changes in the myocardium of the left ventricle and left atrium in patients with acute myeloid leukemia during chemotherapeutic treatment.Materials and methods: the study included 110 patients with newly diagnosed acute myeloid leukemia who were prescribed polychemotherapy with anthracycline drugs. The parameters of the structure and function of the left ventricle were assessed based on transthoracic echocardiography using the specle-tracking technique and determination of the global longitudinal deformation of the left ventricle. Results. In patients with acute myeloid leukemia and verified cardiovascular toxicity, significant changes in the size (EDR, SSR) and volume of the left ventricle (EDV, ESV) were detected. Impaired systolic function was manifested by a decrease in the left ventricular ejection fraction and relative global longitudinal deformation, with a decrease in LV GLS preceding a decrease in LV EF. Diastolic dysfunction in patients with identified cardiovascular complications of anthracycline-containing polychemotherapy was manifested by a decrease in the E/A ratio, e' septal, e' lateral.Conclusions: In patients with acute myeloid leukemia receiving anthracycline-containing polychemotherapy, structural and functional changes in the left ventricular myocardium are detected, consisting in an increase in the size and volume of the left ventricle, as well as in the occurrence of systolic and diastolic dysfunction. A reliable sign of cardiovascular toxicity is a decrease in the global longitudinal deformation of the left ventricle.
format Article
id doaj-art-606599f005f44cd7acff3d1a170e2962
institution Kabale University
issn 2226-762X
2782-1579
language Russian
publishDate 2025-06-01
publisher Private institution educational organization of higher education "Medical University "ReaViz"
record_format Article
series Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
spelling doaj-art-606599f005f44cd7acff3d1a170e29622025-08-20T03:37:29ZrusPrivate institution educational organization of higher education "Medical University "ReaViz"Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье2226-762X2782-15792025-06-0115215215910.20340/vmi-rvz.2025.2.CLIN.13775Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatmentA. V. Chibashova0I. L. Davydkin1Samara State Medical UniversitySamara State Medical UniversityCardiovascular toxicity is one of the most common complications of chemotherapeutic treatment. The most common method for diagnosing cardiovascular toxicity is to assess the structure and function of the left ventricle.The aim of the study was to investigate structural and functional changes in the myocardium of the left ventricle and left atrium in patients with acute myeloid leukemia during chemotherapeutic treatment.Materials and methods: the study included 110 patients with newly diagnosed acute myeloid leukemia who were prescribed polychemotherapy with anthracycline drugs. The parameters of the structure and function of the left ventricle were assessed based on transthoracic echocardiography using the specle-tracking technique and determination of the global longitudinal deformation of the left ventricle. Results. In patients with acute myeloid leukemia and verified cardiovascular toxicity, significant changes in the size (EDR, SSR) and volume of the left ventricle (EDV, ESV) were detected. Impaired systolic function was manifested by a decrease in the left ventricular ejection fraction and relative global longitudinal deformation, with a decrease in LV GLS preceding a decrease in LV EF. Diastolic dysfunction in patients with identified cardiovascular complications of anthracycline-containing polychemotherapy was manifested by a decrease in the E/A ratio, e' septal, e' lateral.Conclusions: In patients with acute myeloid leukemia receiving anthracycline-containing polychemotherapy, structural and functional changes in the left ventricular myocardium are detected, consisting in an increase in the size and volume of the left ventricle, as well as in the occurrence of systolic and diastolic dysfunction. A reliable sign of cardiovascular toxicity is a decrease in the global longitudinal deformation of the left ventricle.https://vestnik.reaviz.ru/jour/article/view/1285acute myeloid leukemia [d015470], antyracyclines [d018943], cardiotoxicity [d066126], systolic heart failure [d054143], left ventricle dysfunction [d018487], ventricular ejection fraction [d013318], left ventricular global longitudinal strain [d000094582]
spellingShingle A. V. Chibashova
I. L. Davydkin
Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
acute myeloid leukemia [d015470], antyracyclines [d018943], cardiotoxicity [d066126], systolic heart failure [d054143], left ventricle dysfunction [d018487], ventricular ejection fraction [d013318], left ventricular global longitudinal strain [d000094582]
title Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
title_full Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
title_fullStr Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
title_full_unstemmed Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
title_short Evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
title_sort evaluation of structural and functional changes in the myocardium in patients with acute myeloid leukemia during chemotherapeutic treatment
topic acute myeloid leukemia [d015470], antyracyclines [d018943], cardiotoxicity [d066126], systolic heart failure [d054143], left ventricle dysfunction [d018487], ventricular ejection fraction [d013318], left ventricular global longitudinal strain [d000094582]
url https://vestnik.reaviz.ru/jour/article/view/1285
work_keys_str_mv AT avchibashova evaluationofstructuralandfunctionalchangesinthemyocardiuminpatientswithacutemyeloidleukemiaduringchemotherapeutictreatment
AT ildavydkin evaluationofstructuralandfunctionalchangesinthemyocardiuminpatientswithacutemyeloidleukemiaduringchemotherapeutictreatment